RCG
OMIC

Rock Creek Group’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Rock Creek Group’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-889
Closed -$207K – 230
2021
Q4 		$207K Buy
+889
New +$345K 0.03% 137

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rock Creek Group's OMIC Position: Q1 2022 in Review

Rock Creek Group sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2022, closing a stake of 889 shares — an estimated $207K sold.

Rock Creek Group first reported a position in OMIC in Q4 2021 and held it in 1 quarter. The position peaked at $207K in Q4 2021. 69 funds tracked by Wall St. Rank hold OMIC as of Q1 2022.

  • Rock Creek Group reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Rock Creek Group sold 889 Singular Genomics Systems, Inc. Common Stock shares in Q1 2022, an estimated $207K.
  • Rock Creek Group first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Rock Creek Group's Singular Genomics Systems, Inc. Common Stock position peaked at $207K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2022.

Based on Rock Creek Group's 13F filing for Q1 2022, filed 11 May 2022.